Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18383539rdf:typepubmed:Citationlld:pubmed
pubmed-article:18383539lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18383539lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:18383539lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18383539lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:18383539lifeskim:mentionsumls-concept:C0025677lld:lifeskim
pubmed-article:18383539lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:18383539lifeskim:mentionsumls-concept:C2353893lld:lifeskim
pubmed-article:18383539lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:18383539pubmed:issue4lld:pubmed
pubmed-article:18383539pubmed:dateCreated2008-4-22lld:pubmed
pubmed-article:18383539pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18383539pubmed:abstractTextTo assess the efficacy, safety, and pharmacology of subcutaneous administration of golimumab in patients with active rheumatoid arthritis (RA) despite treatment with methotrexate (MTX).lld:pubmed
pubmed-article:18383539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18383539pubmed:languageenglld:pubmed
pubmed-article:18383539pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18383539pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18383539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18383539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18383539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18383539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18383539pubmed:statusMEDLINElld:pubmed
pubmed-article:18383539pubmed:monthAprlld:pubmed
pubmed-article:18383539pubmed:issn0004-3591lld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:KayJonathanJlld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:MattesonEric...lld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:WagnerCarrieClld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:HsiaElizabeth...lld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:VisvanathanSu...lld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:HallStephenSlld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:XuZhenhuaZlld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:NashPeterPlld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:DasguptaBhask...lld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:DurezPatrickPlld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:RahmanMahboob...lld:pubmed
pubmed-article:18383539pubmed:authorpubmed-author:HanJohnJlld:pubmed
pubmed-article:18383539pubmed:issnTypePrintlld:pubmed
pubmed-article:18383539pubmed:volume58lld:pubmed
pubmed-article:18383539pubmed:ownerNLMlld:pubmed
pubmed-article:18383539pubmed:authorsCompleteYlld:pubmed
pubmed-article:18383539pubmed:pagination964-75lld:pubmed
pubmed-article:18383539pubmed:dateRevised2010-11-9lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:meshHeadingpubmed-meshheading:18383539...lld:pubmed
pubmed-article:18383539pubmed:year2008lld:pubmed
pubmed-article:18383539pubmed:articleTitleGolimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study.lld:pubmed
pubmed-article:18383539pubmed:affiliationRheumatology Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02114, USA. jkay@partners.orglld:pubmed
pubmed-article:18383539pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18383539pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18383539pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18383539pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18383539lld:pubmed